Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,011
Closed -$578K 231
2024
Q4
$578K Buy
4,011
+18
+0.5% +$3K 0.1% 108
2024
Q3
$651K Buy
+3,993
New +$604K 0.12% 104
2020
Q4
Sell
-4,941
Closed -$441K 145
2020
Q3
$441K Buy
4,941
+1,182
+31% +$107K 0.15% 80
2020
Q2
$352K Sell
3,759
-1,784
-32% -$176K 0.14% 74
2020
Q1
$508K Sell
5,543
-839
-13% -$84.6K 0.27% 52
2019
Q4
$625K Sell
6,382
-117
-2% -$10.3K 0.26% 53
2019
Q3
$558K Buy
+6,499
New +$545K 0.25% 56

Other funds holding LDOS

CFO4Life Group's LDOS Position: Q1 2025 in Review

CFO4Life Group sold out of Leidos (LDOS) in Q1 2025, closing a stake of 4,011 shares — an estimated $578K sold.

CFO4Life Group first reported a position in LDOS in Q3 2019 and held it in 7 quarters. The position peaked at $651K in Q3 2024. 802 funds tracked by Wall St. Rank hold LDOS as of Q1 2025.

  • CFO4Life Group reported no remaining Leidos position as of Q1 2025 after selling out during the quarter.
  • CFO4Life Group sold 4,011 Leidos shares in Q1 2025, an estimated $578K.
  • CFO4Life Group first reported a position in Leidos in Q3 2019 and held it in 7 quarters.
  • CFO4Life Group's Leidos position peaked at $651K in Q3 2024.
  • 802 funds tracked by Wall St. Rank held Leidos as of Q1 2025.

Based on CFO4Life Group's 13F filing for Q1 2025, filed 30 Apr 2025.